Related Experiment Videos
Osteoporosis: prevention, diagnosis, and management
1Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
The American Journal of Medicine
|January 27, 1997
Summary
Osteoporosis is preventable by addressing lifestyle factors like calcium intake and physical activity. Early intervention and bone density measurement are key to preventing fractures, especially hip fractures.
Area of Science:
- Gerontology
- Public Health
- Endocrinology
Background:
- Osteoporosis is a significant public health issue, often preventable through lifestyle modifications.
- Key risk factors include low calcium and vitamin D, physical inactivity, smoking, and excessive alcohol/caffeine intake.
- Hip fractures are a severe consequence of osteoporosis with substantial personal and public health implications.
Purpose of the Study:
- To identify modifiable risk factors for osteoporosis and hip fractures.
- To highlight the importance of bone mineral density (BMD) and clinical risk factors in assessing fracture risk.
- To review effective treatments for retarding postmenopausal bone loss.
Main Methods:
- Review of established risk factors for osteoporosis and hip fractures.
- Identification of additional independent predictors of hip fracture risk from the Study of Osteoporotic Fractures.
- Assessment of fracture risk using BMD measurements (dual-energy x-ray absorptiometry) and clinical evaluation.
Main Results:
- Identified numerous modifiable risk factors, including lifestyle choices and medication use (e.g., long-acting benzodiazepines).
- Highlighted predictors such as maternal hip fracture, weight changes, height, hyperthyroidism, and physical frailty.
- Demonstrated the effectiveness of estrogen, calcitonin, and bisphosphonates in reducing bone loss.
Conclusions:
- Osteoporosis prevention is achievable through early intervention targeting modifiable risk factors.
- Accurate fracture risk assessment combines BMD, fracture history, and clinical risk factors.
- Pharmacological interventions like estrogen, calcitonin, and bisphosphonates are effective in managing postmenopausal bone loss.